Companion Diagnostic Tests Market in Oncology Benefited by Rising Cancer Patients
A new report by Transparency Market Research highlights recent developments in the companion diagnostic tests market in oncology. For many years, drug approval process remained costly, time-consuming, and complex; it still is. However, the adoption of companion diagnostic tests holds much promise to simplify the drug approval procedures. In recent years, companion diagnostic tests have gone through many advancements.
View full press release